- ISIN
- IL0011681371
- Sector
- Healthcare
- Industry
- Medical Devices
- IPO Date
- Aug 21, 2020
Highlights
- Market Cap
- $68.20M
- Enterprise Value
- $35.91M
- EPS (TTM)
- -$1.13
- Total Revenue (TTM)
- $14.52M
- Gross Profit (TTM)
- -$12.44M
- EBITDA (TTM)
- -$52.65M
- Year Range
- $0.73 - $4.95
- Target Price
- $18.00
- ROA (TTM)
- -52.17%
- ROE (TTM)
- -60.21%
- Avg. Volume (1M)
- 1M
- Avg. Volume Value (1M)
- $1.22M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
NNOX Performance Chart
Nano-X Imaging Ltd. (NNOX) is down 65.0% since the beginning of the year. At $1 per share, NNOX is trading 80.2% below its 52-week high of $5. Investors who bought $1,000 worth of NNOX shares 5 years ago would now be looking at an investment worth $35.
Loading charts...
Compare this symbol against anything
Returns By Period
Nano-X Imaging Ltd. (NNOX) has returned -65.00% so far this year and -78.70% over the past 12 months.
Nano-X Imaging Ltd.
- 1D
- 1.54%
- 1M
- -24.62%
- 6M
- -64.11%
- YTD
- -65.00%
- 1Y
- -78.70%
- 3Y*
- -56.74%
- 5Y*
- -48.98%
- 10Y*
- —
- ALL TIME*
- -39.98%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
NNOX Monthly Returns History
Based on dividend-adjusted daily data since Aug 21, 2020, NNOX's average daily return is -0.01%, while the average monthly return is +0.10%. At this rate, an investment would double in approximately 57.8 years.
Historically, 36% of months were positive and 64% were negative. The best month was May 2023 with a return of +191.2%, while the worst month was Feb 2021 at -40.3%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 5 months.
On a daily basis, NNOX closed higher 44% of trading days. The best single day was May 1, 2023 with a return of +68.4%, while the worst single day was Jun 25, 2026 at -44.0%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -2.50% | -13.19% | -4.22% | -24.67% | 12.28% | -39.58% | -15.53% | -65.00% | |||||
| 2025 | 1.11% | -14.97% | -19.31% | 0.70% | 1.79% | 0.98% | -8.90% | -17.83% | -4.39% | -1.89% | 23.42% | -37.50% | -61.11% |
| 2024 | -14.60% | 105.15% | -12.46% | -8.29% | -6.70% | -12.20% | 17.44% | -26.10% | -4.55% | -6.74% | 13.93% | 11.46% | 13.03% |
| 2023 | 24.93% | -20.93% | -20.85% | 5.89% | 191.16% | -12.93% | -19.95% | -32.86% | -21.20% | -23.02% | 32.67% | -4.93% | -13.69% |
| 2022 | -21.94% | -10.57% | 6.80% | -15.22% | 11.21% | 10.57% | 6.55% | 10.55% | -13.82% | 23.80% | -25.00% | -30.70% | -49.24% |
| 2021 | 65.97% | -40.26% | -8.44% | -19.06% | -25.48% | 28.20% | -11.54% | -13.02% | -8.76% | 0.67% | -8.92% | -29.52% | -68.16% |
Benchmark Metrics
Nano-X Imaging Ltd. has an annualized alpha of -24.15%, beta of 1.76, and R2 of 0.08 versus S&P 500 Index. Calculated based on daily prices since August 21, 2020.
- This stock participated in 225.51% of S&P 500 Index downside but only 17.05% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.08 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -24.15%
- Beta
- 1.76
- R²
- 0.08
- Upside Capture
- 17.05%
- Downside Capture
- 225.51%
Return for Risk
Risk / Return Rank
NNOX ranks 5 for risk / return — above 5% of stocks peers on PortfoliosLab. Its historical combined result is below most peers; review the five component ranks for context.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Nano-X Imaging Ltd. (NNOX) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NNOX | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.27 | ||
| Sortino ratioReturn per unit of downside risk | -3.54 | ||
| Omega ratioGain probability vs. loss probability | 0.79 | 1.25 | -0.46 |
| Calmar ratioReturn relative to maximum drawdown | -0.97 | 2.00 | -2.97 |
| Martin ratioReturn relative to average drawdown | -1.66 | 8.49 | -10.16 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Nano-X Imaging Ltd.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Nano-X Imaging Ltd. was 99.02%, occurring on Jul 29, 2026. The portfolio has not yet recovered.
The current Nano-X Imaging Ltd. drawdown is 98.90%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-99.02%Jul 2026 | 5y 6mo | — | 5y 6moJan 2021 - now | — |
-63.36%Sep 2020 | 16d | 3mo 23d | 4mo 9dSep 2020 - Jan 2021 | — |
-14.29%Aug 2020 | 1d | 5d | 6dAug 2020 - Sep 2020 | — |
-8.54%Sep 2020 | 1d | 4d | 5dSep 2020 - Sep 2020 | — |
-0.54%Jan 2021 | 1d | 3d | 3dJan 2021 - Jan 2021 | — |
Drawdown Indicators
| NNOX | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.02% | -56.78% | -42.24% |
Max Drawdown (1Y)Largest decline over 1 year | -82.06% | -9.10% | -72.96% |
Max Drawdown (3Y)Largest decline over 3 years | -93.23% | -18.90% | -74.33% |
Max Drawdown (5Y)Largest decline over 5 years | -97.09% | -25.43% | -71.66% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -98.90% | -1.58% | -97.32% |
Average DrawdownAverage peak-to-trough decline | -82.99% | -10.70% | -72.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 47.56% | 2.14% | +45.42% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Nano-X Imaging Ltd. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Nano-X Imaging Ltd. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for NNOX relative to other companies in the Medical Devices industry. Currently, NNOX has a P/S ratio of 4.5. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for NNOX in comparison with other companies in the Medical Devices industry. Currently, NNOX has a P/B value of 0.5. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with NNOX
Add Nano-X Imaging Ltd. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with NNOX